BioSpace News Archive

Clinical lab techs are in high demand in healthcare, pharma and biotech. Here’s a look at what they do, career advancement opportunities within the role and the training required to become one.

The layoffs come as the company posts nearly $300 million in net losses and just over $80 million in revenue during the first quarter of 2023.

The pharma company will lay off 170 employees and drop all candidates but one, as it seeks to rebuild its business.

The delay and guidance downgrade follow a spate of operational issues that have affected three of Catalent’s major manufacturing sites.

Ardelyx, Inc. (Nasdaq: ARDX) today announced that a new analysis from IBSRELA Phase 3 trial, T3MPO-2, was presented in a poster presentation at the 2023 Digestive Disease Week Conference (DDW 2023) that is now underway in Chicago, Illinois.

Omeq Medical Ltd. a portfolio company of The Trendlines Group Ltd. (SGX: 42T) (OTCQX: TRNLY), announced today that it has received regulatory clearance from the United States Food and Drug Administration (“FDA”) for its EpiFinder, which assists physicians to accurately position an epidural needle while performing the standard Loss of Resistance (“LOR”) technique.

Delix Therapeutics (the “Company”), a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, today announced the regulatory approval and initiation of recruitment of a phase I clinical trial of lead candidate, DLX-001, a non-hallucinogenic psychoplastogen.

Lassen Therapeutics will present new preclinical and Phase I data of LASN01, a potential first-in-class IL-11 receptor (IL-11R) blocking antibody in development for treatment of pulmonary fibrosis, at the American Thoracic Society (ATS) Annual Meeting being held in Washington DC, May 19-24, 2023.

Lineage Cell Therapeutics, Inc. today announced that the Company has received a grant from the California Institute for Regenerative Medicine (CIRM) , to support the 1st Annual Spinal Cord Injury Investor Symposium.

Nascent Biotech, Inc. announced today that the Company has been selected for a poster presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting held in Chicago on June 2-6, 2023.